Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eva Vecvagare
Duration of Previous Treatment as a Prognostic Factor in Metastatic Colorectal Cancer Treated With Trifluridine/Tipiracil
Molecular and Clinical Oncology
Cancer Research
Oncology
Related publications
Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib
Oncologist
Cancer Research
Medicine
Oncology
Cost Effectiveness of Trifluridine/Tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales
Clinical Colorectal Cancer
Oncology
Gastroenterology
Real-World Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib
Clinical Colorectal Cancer
Oncology
Gastroenterology
A Retrospective Study of Trifluridine/Tipiracil in Pretreated Metastatic Colorectal Cancer Patients in Clinical Practice
Colorectal Cancer
Oncology
Gastroenterology
Emerging Combination Therapies for Metastatic Colorectal Cancer &Ndash; Impact of Trifluridine/Tipiracil
Cancer Management and Research
Oncology
Review of Metastatic Colorectal Cancer Treatment Pathways and Early Clinical Experience of Trifluridine/Tipiracil in the UK Named Patient Programme
BMC Cancer
Cancer Research
Oncology
Genetics
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of Two Randomized Clinical Trials
Clinical Colorectal Cancer
Oncology
Gastroenterology
Trifluridine/Tipiracil: Old Drug, New Tricks
Journal of the Advanced Practitioner in Oncology
Carcinoembryonic Antigen as a Prognostic Factor in Colorectal Cancer With Liver Metastases
Journal of Cancer Therapy
